Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Satoshi Fujii

6PUBLICATIONS

38CO-AUTHORS

Molecular targetsHaematological tumoursOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer diagnosis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jan 17, 2025

Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.

Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin

|Aug 01, 2024

Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial.

Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh

|Oct 19, 2020

FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.

Hiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura

|Jul 11, 2020

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Yuki Saito, Ryuichi Hayashi, Yoshiyuki Iida

|Mar 31, 2018

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients.

Tomohiro Kadota, Ken Hatogai, Tomonori Yano

|Jan 27, 2018

Comparison of MR Imaging and Dual-Energy CT for the Evaluation of Cartilage Invasion by Laryngeal and Hypopharyngeal Squamous Cell Carcinoma.

H Kuno, K Sakamaki, S Fujii

Pageof 1

Frequent Collaborators

2 joint publications

Yoshiaki Nakamura

2 joint publications

Takayuki Yoshino

2 joint publications

Hideaki Bando

2 joint publications

Yoshito Komatsu

2 joint publications

Hiroya Taniguchi

1 joint publications

K Sakamaki

1 joint publications

K Sekiya

1 joint publications

Chan-Young Ock

1 joint publications

R Hayashi

1 joint publications

T Yamanaka

Frequent Collaborators

2 joint publications

Yoshiaki Nakamura

2 joint publications

Takayuki Yoshino

2 joint publications

Hideaki Bando

2 joint publications

Yoshito Komatsu

Top Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on : Apr 30, 2021

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

See more related videos

Top Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on : Apr 30, 2021

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

See more related videos